Assessment of regional GABAA receptor binding using 18F-fluoroflumazenil positron emission tomography in spastic type cerebral palsy

NeuroImage

Volumn 34, Issue 1, 2007, Pages 19-25

  Lee, Jong Doo ^a   Park, Hae Jeong ^a   Park, Eun Sook ^a   Kim, Dong Goo ^a   Rha, Dong Wook ^a   Kim, Eung Yeop ^a   Kim, Dong Ik ^a   Kim, Jae Jin ^a   Yun, Mijin ^a   Ryu, Young Hoon ^a   Lee, Jinu ^a   Jeong, Jae Min ^b   Lee, Dong Soo ^b   Lee, Myung Chul ^b   Park, Chang Il ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

18F fluoroflumazenil; Cerebral palsy; GABAA receptor; Motor dysfunction; Plasticity

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; FLUMAZENIL; FLUORINE 18; FLUOROFLUMAZENIL; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BRAIN STEM; CEREBRAL PALSY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MOTOR PERFORMANCE; NERVE CELL PLASTICITY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR BINDING; SYMPTOM; VISUAL CORTEX;

ADOLESCENT; ADULT; BINDING SITES; BRAIN STEM; CEREBRAL PALSY; CHILD; FEMALE; FLUMAZENIL; FLUORINE RADIOISOTOPES; HUMANS; MALE; MOTOR CORTEX; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, GABA-A;

EID: 33751073707     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2006.09.004     Document Type: Article

References (42)

1. Back S.A., Gan X., Li Y., Rosenberg P.A., and Volpe J.J. Maturation-dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion. J. Neurosci. 18 (1998) 6241-6253
2. Behar T.N., Schaffner A.E., Scott C.A., O'Conell C., and Barker J.L. Differential response of cortical plate and ventricular zone cells to GABA as a migration stimulus. J. Neurosci. 18 (1998) 6378-6387
3. Ben-Ari Y. Excitatory actions of GABA during development: the nature of the nurture. Nat. Rev., Neurosci. 3 (2002) 728-739
4. Boletus A., and Bordey A. GABA release and uptake regulate neuronal precursor migration in the postnatal subventricular zone. J. Neurosci. 24 (2004) 7623-7631
5. Butefisch C.M., Davis B.C., Wise S.P., Sawaki L., Kopylev L., Classen J., and Cohen L.G. Mechanism of use-dependent plasticity in the human motor cortex. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 3661-3665
6. Capaday C., and Rasmussen D.D. Expansion of receptive fields in motor cortex by local blockade of GABAA receptors. Exp. Brain Res. 153 (2003) 118-122
7. Capute A.J., and Accardo P.J. Cerebral palsy: the spectrum of motor dysfunction. In: Capute A.J., and Accordo P.J. (Eds). Developmental Disabilities in Infancy and Childhood (1996), Paul Brookes, Baltimore 81-94
8. 18F]fluoroflumazenil for central benzodiazepine receptor imaging. Nucl. Med. Biol. 32 (2005) 263-268
9. A receptors measured with positron emission tomography. Ann. Neurol. 49 (2001) 618-626
10. Fagiolini M., and Hensch T. Inhibitory threshold for critical-period activation in primary visual cortex. Nature 404 (2000) 183-186
11. Genovese C.R., Lazar N.A., and Nichols T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. NeuroImage 15 (2002) 870-878
12. Gilbert S.L., Zhang L., Foster M.L., Anderson J.R., Iwase T., Soliven B., Donahue L.R., Sweet H.O., Bronson R.T., Davisson M.T., Wollmann R.L., and Lahn B.T. Trak1 mutation disrupts GABAA receptor homeostasis in hypertonic mice. Nat. Genet. 38 (2006) 245-250
13. Hensch T.K., Fagiolini M., Metaga N., Stryker M.P., Baekkeskov S., and Kash S.F. Local GABA circuit control of experience-dependent plasticity in developing visual cortex. Science 282 (1998) 1504-1508
14. Himmelmann K., Beckung H.E., Hagberg B., and Uvebrant P. The changing panorama of cerebral palsy in Sweden. IX. Prevalence and origin in the birth-year period 1995-1998. Acta Pediatr. 94 (2005) 287-294
15. Hoon A.H., Lawrie W.T., Melhem E.R., Reinhardt E.M., van Zijl P.C.M., Solaiyappan M., Jiang H., Johnston M.V., and Mori S. Diffusion tensor imaging of periventricular leukomalacia shows affected sensory cortex white matter pathways. Neurology 59 (2006) 752-756
16. Johnston M.V., Trescher W.H., Ishida A., and Nakajima W. Neurobiology of hypoxic-ischemic injury in the developing brain. Pediatr. Res. 49 (2001) 735-741
17. Koman L.A., Smith B.P., and Shilt J.S. Cerebral palsy. Lancet 363 (2004) 1619-1631
18. Kuban K.C.K., and Leviton A. Cerebral palsy. N. Engl. J. Med. 330 (1994) 188-195
19. Kwong K.L., Wong Y.C., Fong C.M., Wong S.N., and So K.T. Magnetic resonance imaging in 122 children with spastic cerebral palsy. Pediatr. Neuroradiol. 31 (2004) 172-176
20. Lin J.P. The cerebral palsies: a physiological approach. J. Neurol. Neurosurg. Psychiatry 74 Suppl. 1 (2003) i23-i29
21. Lin S., and Bergles D.E. Synaptic signaling between GABAergic interneurons and oligodendrocyte precursor cells in the hippocampus. Nat. Neurosci. 7 (2004) 24-32
22. 11C]flumazenil. Brain 123 (2000) 2289-2296
23. Lu X., and Ashe J. Anticipatory activity in primary motor cortex codes memorized movement sequences. Neuron 45 (2005) 967-973
24. 18F]FFMZ), a potential GABA receptor ligand for PET. Nucl. Med. Biol. 31 (2004) 291-295
25. Muir J.K., Lobner D., Monyer H., and Choi D.W. GABAA receptor activation attenuates excitotoxicity but exacerbates oxygen-glucose deprivation-induced neuronal injury in vitro. J. Cereb. Blood Flow Metab. 16 (1996) 1211-1218
26. Nelson K.B. Can we prevent cerebral palsy?. N. Eng. J. Med. 349 (2003) 1765-1769
27. Neufeld M.D., Frigon C., Graham A.S., and Mueller B.A. Maternal infection and risk of cerebral palsy in term and preterm infants. J. Perinatol. 25 (2005) 108-113
28. Niimura K., Muzik O., Chugani D.C., Shen C., and Chugani H.T. [11C] flumazenil PRT: activity images versus parametric images for the detection of neocortical epileptic foci. J. Nucl. Med. 40 (1999) 1985-1991
29. Nuñez J.L., Alt J.J., and McCarthy M.M. A novel model for prenatal damage II. Long-term deficit in hippocampal cell number and hippocampal-dependent behavior following neonatal GABAA receptor activation. Exp. Neurol. 181 (2003) 270-280
30. Olsen R.W., McCabe R.T., and Wamsley J.K. GABAA receptor subtypes: autoradiographic comparison of GABA, benzodiazepine and convulsant binding sites in rat central nervous system. J. Chem. Neuroanat. 3 (1990) 59-76
31. Owens D.F., and Kriegstein A.R. Is there more to GABA than synaptic inhibition?. Nat. Rev., Neurosci. 3 (2002) 715-727
32. Schneider C., Devanne H., Lavoie B.A., and Capaday C. Neural mechanisms involved in the functional linking of motor cortical points. Exp. Brain Res. 146 (2002) 86-94
33. A neurotransmission and cerebral ischemia. J. Neurochem. 77 (2001) 353-371
34. Sheean G. The pathophysiology of spasticity. Eur. J. Neurol. 9 Suppl. 1 (2002) 3-9
35. Thickbroom G.W., Byrnes M.L., Archer S.A., Nagarajan L., and Mastraglia F.L. Differences in sensory and motor cortical organization following brain injury early in life. Ann. Neurol. 49 (2001) 320-327
36. 11C]flumazenil PET. Brain 128 (2005) 1323-1329
37. Volpe J.J. Neurobiology of periventricular leukomalacia in the premature infant. Pediatr. Res. 50 (2001) 553-562
38. Winter S., Autry A., Boyle C., and Yeargin-Allsopp M. Trends in the prevalence of cerebral palsy in a population-based study. Pediatrics 110 (2002) 1220-1225
39. Wu Y.W., and Colford J.M. Chorioamnionitis as a risk factor for cerebral palsy: a meta-analysis. JAMA 284 (2000) 1417-1424
40. Wu Y.W., Escobar G.J., Grether J.K., Croen L.A., Greene J.D., and Newman T.B. Chorioamnionitis and cerebral palsy in term and near-term infants. JAMA 290 (2003) 2677-2684
41. 11C-flumazenil PET study. J. Nucl. Med. 46 (2005) 1973-1979
42. Zieman U., Muellbacher W., Hallett M., and Cohen L.G. Modulation of practice-dependent plasticity in human motor cortex. Brain 124 (2001) 1171-1181